MRI staging using gadodiamide for soft-tissue tumors of the head and neck region. Results from a phase II trial and a 5-year clinical follow-up

European Journal of Radiology

Volumn 39, Issue 3, 2001, Pages 168-175

  Ekholm, S E ^a   Bjork Eriksson T ^a   Western, A ^b   Nellstrom H ^a   Jonsson, E ^c   Johansson, A ^a   Lonn L ^a   Mercke, C ^a   Tollesson, P O ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NYCOMED IMAGING AS   (Norway)

^c Nycomed AB   (Sweden)

Author keywords

5 year survival; Gadodiamide; Head and neck; MRI; Tumour

Indexed keywords

DIAGNOSIS; MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; TISSUE; TUMORS;

CONVENTIONAL SPIN-ECHO SEQUENCES;

RADIOLOGY;

ECHO CONTRAST MEDIUM; GADODIAMIDE;

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; SOFT TISSUE TUMOR; THIRST;

CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SOFT TISSUE NEOPLASMS; TIME FACTORS;

EID: 0034857847     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(01)00371-0     Document Type: Article

References (11)

1. Parotid gland: Plain and gadolinium-enhanced MR imaging
2. Multicenter trial of gadoteridol, a nonionic gadolinium chelate, in patients with suspected head and neck pathology
3. MR imaging with Gd-DTPA in lesions of the head and neck
4. Schwannoma of the trachea
5. Oral cavity, oropharynx, and salivary glands
6. Diagnostic imaging aids to head and neck radiation oncology
7. Comparison of T2 weighted fat suppressed turbo spin echo and contrast enhanced T1 weighted spin echo MRI in nasopharyngeal carcinoma
8. MR-imaging with Gd-DTPA in carcinomas of tongue, oro-hypopharynx
9. Efficacy of gadoteridol for magnetic resonance imaging of extracranial head and neck pathology